PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Sign in See plans ↓
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
✗ Search by company or clause
✗ Video walkthroughs
✗ Podcast episodes
✗ MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
All (1752) Social Media & Digital (720) HCP Hospitality & Meetings (431) Data & Publications (321) Off-label Promotion (219) Patient Organisations (44) Transfers of Value (9) Promotional Material (4) Samples & Gifts (2)
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 720 results · Social Media & Digital  · Clear
🔒 Subscribers only
AUTH/3229/7/19
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GSK breached ABPI Code over Relvar Ellipta ‘superior’ asthma control ad lacking context (AUTH/3229/7
A ‘concerned UK health professional’ complained about a two-page Relvar Ellipta (fluticasone furoate/vilanterol) advertisement placed in Pulse (April 2019) by GlaxoSmithKline UK Limited.Page 1 …
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3153/1/19
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Anonymous v Otsuka Europe (AUTH/3153/1/19)
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3179/4/19
Social Media & Digital Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GSK
A concerned UK health professional complained after learning (from an earlier related case) that an agency had used material that was not certified.The promotion was a dynamic, rotating four-frame …
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3131/12/18
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Napp
An anonymous, non-contactable complainant (a “concerned health professional”) alleged that meeting advertisements on Facebook and Twitter for meetings sponsored by pharma companies (including N…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3133/12/18
Social Media & Digital Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Novo Nordisk breached ABPI Code over missing sponsorship declaration for APPG diabetes summit materi
An anonymous, non-contactable health professional complained about a flyer for an International Diabetes Summit (House of Commons, December 2018) organised by the All Party Parliamentary Group (APP…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3130/12/18
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GlaxoSmithKline
An anonymous complainant raised two issues: (1) a poster/invitation for a pharmacists’ CPD meeting (asthma medication reviews and a minor illness referral service) showing a retail pharmacy group…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3070/9/18
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Johnson & Johnson
A British Medical Journal paper (Goldacre et al, published online 12 September 2018) assessed whether sponsors posted results on the EU Clinical Trials Register (EUCTR) within 12 months of completi…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3128/12/18
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Janssen
An individual complained about a leaflet promoting Imbruvica (ibrutinib) on Janssen-Cilag’s exhibition stand at a UK Oncology Nurses Society meeting in Glasgow (November 2018).The leaflet (ref PH…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3112/11/18
Social Media & Digital Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Lilly rheumatology website
A UK health professional complained about Lilly’s rheumatology website (www.lillyrheumatology.co.uk), saying it was unclear if it was promotional or an HCP resource.The site required users to sel…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3109/10/18
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
AstraZeneca website
A UK health professional complained about AstraZeneca UK’s HCP medicines website pages for Forxiga (dapagliflozin), Onglyza (saxagliptin) and Symbicort (budesonide/formoterol).Forxiga: complaint …
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3067/9/18
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Chiesi
A member of the public (a friend of a Chiesi employee) complained about Chiesi’s compliance procedures and alleged excessive hospitality/payments to a named professor, including business class fl…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3064/9/18
Social Media & Digital Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
ViiV Healthcare
Gilead Sciences Europe complained about ViiV Healthcare’s promotion of Juluca (dolutegravir/rilpivirine), a 2-drug HIV regimen for adults virologically suppressed on a stable ARV regimen for at l…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3108/10/18
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Mitsubishi Tanabe Pharma Europe
A UK health professional complained that Mitsubishi Tanabe Pharma Europe’s corporate website product pages effectively promoted prescription-only medicines (POMs) to the public.The products refer…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3011/1/18
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GSK v AstraZeneca
GlaxoSmithKline complained about an AstraZeneca PLC press release dated 10 November 2017 titled “Benralizumab receives positive EU CHMP opinion for severe, uncontrolled eosinophilic asthma”.The…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3049/6/18
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Bristol-Myers Squibb
An anonymous, non-contactable complainant challenged the colour of the inverted triangle symbol on Bristol-Myers Squibb’s UK ‘Current products’ webpage.The page (ref MLTUK1701479-04) was cert…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3047/6/18
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
A Menarini
An anonymous contactable UK health professional complained about a Migard (frovatriptan) advertisement on the BMJ website.The ad did not include prescribing information; instead it provided a singl…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3037/4/18
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Shield Therapeutics
An anonymous UK health professional complained about content on Shield Therapeutics’ corporate website relating to Feraccru (ferric maltol) and pipeline products PT20, PT30 and PT40.The complaina…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3012/1/18
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Pierre Fabre
Pierre Fabre made a voluntary admission of Code breaches relating to materials for Toviaz (fesoterodine) used at an April 2017 cycle meeting and then emailed to representatives (email dated 2 May 2…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3098/9/18
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
A Menarini
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3090/9/18
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Novartis
The Director took up a BMJ paper (Goldacre et al, 12 Sept 2018) assessing whether sponsors posted trial results to the EU Clinical Trials Register (EUCTR) within 12 months of completion (final comp…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3134/12/18
Social Media & Digital Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Shield
An anonymous complainant (described as a concerned UK health professional) challenged content in the FAQs on Shield’s Feraccru (ferric maltol) website for health professionals.FAQ 1 (Hb): The sit…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3088/9/18
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Ipsen
The PMCPA Director initiated a complaint (under Paragraph 5.1) after a BMJ paper (Goldacre et al, published online 12 September 2018) assessed whether sponsors posted due trial results to the EU Cl…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3034/4/18
Social Media & Digital Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
AstraZeneca ‘Fixing Dad’ HCP webpage ruled promotional in context—missing prescribing information
An anonymous UK health professional complained about a ‘Fixing Dad’ video trailer embedded on AstraZeneca UK’s Medicines website within the diabetes section.The page invited HCPs to arrange a…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3038/4/18
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Novartis employee’s LinkedIn activity ruled promotional
An anonymous, contactable UK health professional complained about a named Novartis employee’s activity on their personal LinkedIn account.The activity related to two prescription-only medicines (…
Clauses: NONE
2018 🔒 Subscribe
← Prev 16 17 18 19 20 21 22 Next → Page 19 of 30 — 720 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Most Popular
Team 5
Up to 5 team members
£999
per year (£200/seat)
£200/person — the most cost-effective team option
  • 5 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • New cases added monthly
  • Admin management portal
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews